Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comparison Between Mismatch Repair Protein Immunostaining and Microsatellite Instability Testing
Anticancer Research · 2023
DOI: 10.21873/anticanres.16332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Hyunjin Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Center, Seegene Medical Foundation, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathology Center, Seegene Medical Foundation, Seoul, Republic of Korea.
- Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea hyun-soo.kim@samsung.com.
Zitieren
APA
Kim, H., & Kim, H. S. (2023). Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comparison Between Mismatch Repair Protein Immunostaining and Microsatellite Instability Testing. Anticancer Research. https://doi.org/10.21873/anticanres.16332
Vancouver
Kim H, Kim HS. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comparison Between Mismatch Repair Protein Immunostaining and Microsatellite Instability Testing. Anticancer Research. 2023. doi:10.21873/anticanres.16332
BibTeX
@article{Kim2023,
author = {Kim, Hyunjin and Kim, Hyun-Soo},
title = {Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comparison Between Mismatch Repair Protein Immunostaining and Microsatellite Instability Testing},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16332}
}
EUVIMED